Within each D’Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
Rati-Fi® Informed Consent
Rati-Fi® Informed Consent
Within each D’Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
